PolyPid Ltd. (PYPD) shareholders
PYPDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 25, 2026Score 5/30
$6.54+0.39 (+6.34%)
Close on Nov 17, 2026Market cap $119.05MP/E 3.1Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
18.0%
3M of 18M shares
Institutional holders
33
14 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Salamon Steven A J Joint filing with Rosalind Advisors, Inc. (9.90%), Aharon Gil (9.90%) and 1 more | 5,483,443 | 9.90% | 13G (passive) amendment | Dec 31, 2025 |
| Rosalind Master Fund L.P. Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 5,384,813 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Aharon Gil Joint filing with Rosalind Advisors, Inc. (9.90%), Salamon Steven A J (9.90%) and 1 more | 5,124,011 | 9.90% | 13G (passive) amendment | Jul 31, 2026 |
| Morris Kahn Joint filing with Aurum Ventures M.K.I. Ltd. (28.10%) | 5,001,561 | 28.10% | 13G (passive) amendment | Jun 30, 2025 |
| Aurum Ventures M.K.I. Ltd. | 5,001,561 | 24.40% | 13G (passive) amendment | Mar 31, 2026 |
| Rosalind Advisors, Inc. Joint filing with Salamon Steven A J (9.90%), Aharon Gil (9.90%) and 1 more | 4,081,088 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Geneva Trust Company (GTC) SA Joint filing with Rodney Hodges (13.40%), Geneva Holding Company (GHC) SA (13.40%) and 2 more | 2,722,707 | 13.40% | 13G (passive) amendment | Jun 30, 2026 |
| POD Sarl Joint filing with Rodney Hodges (19.90%), Geneva Holding Company (GHC) SA (19.90%) and 3 more | 2,242,767 | 19.90% | 13G (passive) amendment | Dec 31, 2024 |
| AIGH Capital Management LLC Joint filing with Orin Hirschman (9.80%) | 1,793,117 | 9.80% | 13G (passive) amendment | Dec 31, 2025 |
| Orin Hirschman Joint filing with AIGH Capital Management LLC (7.70%) | 1,194,108 | 7.70% | 13G (passive) | Jun 30, 2025 |
| Yehuda Nir | 1,071,258 | 10.10% | 13G (passive) amendment | Mar 31, 2025 |
| Aharon Lukach | 538,610 | 5.20% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PYPD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 1,504,741 | 8.27% | $7.64M | −88,846 | 0.48% |
| Rosalind Advisors, Inc. | 389,455 | 2.14% | $1.98M | −208,471 | 0.73% |
| DAFNA Capital Management LLC | 207,900 | 1.14% | $1.06M | – | 0.20% |
| Morgan Stanley | 123,136 | 0.68% | $625.53K | −53,756 | 0.00% |
| Renaissance Technologies LLC | 116,619 | 0.64% | $592.43K | +98,023 | 0.00% |
| Marshall Wace, Llp | 115,014 | 0.63% | $584.27K | New | 0.00% |
| ADAR1 Capital Management, LLC | 103,950 | 0.57% | $528.07K | – | 0.02% |
| Symmetry Peak Management LLC | 100,881 | 0.55% | $512.48K | +13,688 | 0.14% |
| J. Goldman & Co LP | 99,183 | 0.54% | $503.85K | −50,316 | 0.01% |
| Jane Street Group, LLC | 83,126 | 0.46% | $422.28K | +61,484 | 0.00% |
| Quadrature Capital Ltd | 70,939 | 0.39% | $360.37K | New | 0.00% |
| Connective Capital Management, LLC | 67,600 | 0.37% | $343.41K | New | 0.24% |
| Citadel Advisors LLC | 42,282 | 0.23% | $214.79K | −15,487 | 0.00% |
| Susquehanna International Group, Llp | 40,027 | 0.22% | $203.34K | New | 0.00% |
| Lumbard & Kellner, LLC | 38,200 | 0.21% | $194.06K | – | 0.06% |
| Hrt Financial LP | 37,304 | 0.20% | $189.00K | New | 0.00% |
| XTX Topco Ltd | 35,047 | 0.19% | $178.04K | +5,584 | 0.00% |
| Virtu Financial LLC | 18,851 | 0.10% | $96.00K | New | 0.00% |
| UBS Group AG | 18,484 | 0.10% | $93.90K | New | 0.00% |
| Axq Capital, LP | 17,097 | 0.09% | $86.85K | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 33 | 3M | 18.0% | 14 / 5 | 6 / 0 | 1M | 0M |
| Q1 2026 | 19 | 3M | 17.1% | 2 / 3 | 6 / 2 | 0M | 0M |
| Q4 2025 | 19 | 3M | 16.5% | 5 / 4 | 5 / 2 | 0M | 0M |
| Q3 2025 | 16 | 3M | 15.6% | 4 / 4 | 2 / 3 | 0M | 0M |
| Q2 2025 | 15 | 3M | 15.9% | 4 / 6 | 2 / 2 | 1M | 0M |
| Q1 2025 | 13 | 3M | 14.0% | 1 / 1 | 1 / 2 | 0M | 0M |
| Q4 2024 | 14 | 2M | 13.6% | 3 / 3 | 4 / 1 | 1M | 0M |
| Q3 2024 | 12 | 2M | 10.6% | 3 / 3 | 3 / 0 | 1M | 0M |
| Q2 2024 | 9 | 1M | 6.6% | 1 / 2 | 2 / 0 | 0M | 0M |
| Q1 2024 | 8 | 1M | 6.1% | 3 / 1 | 2 / 0 | 1M | 0M |
| Q4 2023 | 5 | 0M | 0.1% | 1 / 1 | 3 / 0 | 0M | 0M |
| Q3 2023 | 4 | 0M | 0.1% | 1 / 1 | 2 / 11 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Dikla Czaczkes Akselbrad | Chief Executive Officer, Director | 934 | 0.01% | Jul 17, 2026 |
| Ori Warshavsky | Chief Operating Officer - US | 267 | 0.00% | Jul 17, 2026 |
| Dalit Fellous Hazan | Deputy CEO, EVP, RD, CRA | – | – | Jul 17, 2026 |
| Jonathan Missulawin | Chief Financial Officer | – | – | Jul 17, 2026 |
| Joseph BenAmram | Director | – | – | Jul 17, 2026 |
| Brooke Story | Director | – | – | Jul 17, 2026 |
| Robert Benjamin Stein | Director | – | – | Jul 17, 2026 |
| Yechezkel Barenholz | Director | 2,760 | 0.02% | Jul 17, 2026 |
| Nir Dror-Darwish | Director | – | – | Jul 17, 2026 |
| Itzhak Krinsky | Director | 833 | 0.00% | Jul 17, 2026 |
| Yitzchak Shlomo Jacobovitz | Director | – | – | Apr 6, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
9.16%
0M shares short
Days to cover
3.5
At 0M shares a day
Change since last report
+98.3%
From 0M shares
Short volume, 20 days
37.3%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of PolyPid's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,582 shares on Sep 2, 2026 over the last 90 days.
See a number that looks wrong?